Dianthus Therapeutics Recognized Among Fortune’s 2026 Best Workplaces In BioPharma
Key Highlights
- ➤Dianthus Therapeutics selected among top 30 small- and medium-sized U.S. biopharma workplaces
- ➤Dianthus makes inaugural appearance on Fortune’s 2026 Best Workplaces in BioPharma list
- ➤Great Place To Work analyzed over 1.3 million confidential employee surveys
- ➤Dianthus continues expanding its team through a fully remote work environment
Expert Statements
Marino Garcia, Chief Executive Officer of Dianthus Therapeutics
“As Dianthus enters a new phase of growth, being named one of Fortune's Best Workplaces in BioPharma underscores how we are building a company capable of transforming patient lives, and a place where exceptional people can thrive, connect and do their best work, regardless of location.”
Marino Garcia, Chief Executive Officer of Dianthus Therapeutics
“I am incredibly proud of the team that has built this culture together. High performance, trust and a shared commitment to our values are what set Dianthus apart, and this achievement reflects what our employees make possible every day.”
NEW YORK and WALTHAM, Mass., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to developing next-generation therapies to transform the treatment of severe autoimmune diseases, today announced it was selected by Great Place To Work® and Fortune magazine for the 2026 Fortune Best Workplaces in BioPharma™ List. This is Dianthus’ inaugural appearance on the list, ranking among the top 30 small- and medium-sized biotechnology and pharmaceutical companies in the United States. The Company was recognized for fostering a high-trust and engaging workplace culture.
“As Dianthus enters a new phase of growth, being named one of Fortune's Best Workplaces in BioPharma underscores how we are building a company capable of transforming patient lives, and a place where exceptional people can thrive, connect and do their best work, regardless of location,” said Marino Garcia, Chief Executive Officer of Dianthus Therapeutics. “I am incredibly proud of the team that has built this culture together. High performance, trust and a shared commitment to our values are what set Dianthus apart, and this achievement reflects what our employees make possible every day.”
Get started
Create a free account to read the full story.